Filter
509
Text search:
microbiological
risk
assessment
Featured
Recommendations
73
New Publications
137
Language
Document type
No document type
254
Guidelines
110
Studies & Reports
74
Manuals
46
Strategic & Response Plan
14
Situation Updates
6
Training Material
3
Brochures
1
Fact sheets
1
Countries / Regions
India
48
Western and Central Europe
19
Global
14
Ethiopia
11
Kenya
11
South Africa
11
Tanzania
10
Bangladesh
10
Latin America and the Carribbean
10
Nigeria
9
Uganda
8
Eastern Europe
8
Sierra Leone
7
Africa
7
Malawi
6
Ghana
5
Nepal
5
Eswatini/ Swaziland
5
Zimbabwe
4
Zambia
4
Liberia
3
Germany
3
Rwanda
3
Namibia
3
Botswana
3
Guinea
2
Congo, Democratic Republic of
2
Pakistan
2
Mozambique
2
North Macedonia
2
Ukraine
2
Myanmar / Burma
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Tajikistan
2
Vietnam
2
Burkina Faso
1
Senegal
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
USA
1
Saudi Arabia
1
Philippines
1
Iraq
1
Gambia
1
Indonesia
1
Sudan
1
Benin
1
Colombia
1
Libya
1
Sri Lanka
1
West and Central Africa
1
Bhutan
1
Laos
1
Australia
1
North America
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
167
Clinical Guidelines
60
Key Resources
58
Pharmacy & Technologies
23
Public Health
15
Women & Child Health
15
Capacity Building
11
Toolboxes
AMR
90
TB
71
COVID-19
27
Rapid Response
22
Planetary Health
21
Pharmacy
18
2.0 Rapid Response
18
NTDs
15
Ebola & Marburg
12
HIV
12
Caregiver
12
Natural Hazards
8
Cholera
6
Conflict
3
Refugee
3
Global Health Education
3
Malaria
3
Disability
2
Polio
2
Zika
2
Mental Health
2
Health Financing Toolbox
1
NCDs
1
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr
...
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked med
...
Accessed Febr. 6, 2020
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
A key purpose of the Recovery Toolkit is to support countries in the reactivation of health services which may have suffered as a result of the emergency. These services include ongoing programmes such as immunization and vaccinations, maternal and child health services, and noncommunicable diseases
...
The report summarizes the estimates of the burden of disease attributable to unsafe drinking water, sanitation, and hygiene for the year 2019 for four health outcomes - diarrhoea, acute respiratory infections, soil-transmitted helminthiases, and undernutrition - which are included in the reporting o
...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G
...
Disinfection of drinking-water supplies has been one of the most significant public health advancements of the last century with respect to reducing waterborne disease.
Although chlorine has been used as the disinfectant of choice for public drinking-water supplies for the past century, a numbe ...
Although chlorine has been used as the disinfectant of choice for public drinking-water supplies for the past century, a numbe ...
Haematologica has published European guidelines for empirical and targeted antibacterial therapy forfebrile neutropenic patients in the era of emerging resistance (ECIL-4). Indeed, collateral damage by broad-spectrum antibiotic therapy includes selection of multidrugresistant pathogens, and incr
...
This curricula guide builds on several existing products of WHO and partners, aimed at supporting countries in their effort to address the first objective of the GAP-AMR (to improve awareness and understanding of AMR). It is targeted specifically at health educators and policy planners, and applies
...
In light of the decline in new Ebola cases, strategies are now needed to scale down the activities and bed capacities in Ebola care facilities. These facilities include Ebola treatment units, community care centres, Ebola treatment centres and isolation centres. The Governments of Guinea, Liberia an
...
The workshop is structured around 13 learning modules. The first module (Introduction) gives an overview of WSPs. The last module (Module 12) introduces participants to the quality assurance tool for WSPs (WHO & IWA, 2012). Modules 1–11 relate explicitly to the WSP manual produced by IWA and WHO (
...
Int J Health Geogr. 2002; 1: 5.
Published online 2002 Dec 20. doi: 10.1186/1476-072X-1-5
PMCID: PMC149400
PMID: 12537588
